C4 Therapeutics Stock Forecast - Double Exponential Smoothing
| CCCC Stock | USD 2.15 0.03 1.38% |
The Double Exponential Smoothing forecasted value of C4 Therapeutics on the next trading day is expected to be 2.15 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.89. CCCC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast C4 Therapeutics stock prices and determine the direction of C4 Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of C4 Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of C4 Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.36) | EPS Estimate Current Year (1.52) | EPS Estimate Next Year (1.29) | Wall Street Target Price 9.8571 | EPS Estimate Current Quarter (0.39) |
Using C4 Therapeutics hype-based prediction, you can estimate the value of C4 Therapeutics from the perspective of C4 Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards C4 Therapeutics using C4 Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards CCCC using crowd psychology based on the activity and movement of C4 Therapeutics' stock price.
C4 Therapeutics Short Interest
A significant increase or decrease in C4 Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards CCCC. Short interest can provide insight into the potential direction of C4 Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 2.1 | Short Percent 0.0794 | Short Ratio 3.89 | Shares Short Prior Month 7.2 M | 50 Day MA 2.3168 |
C4 Therapeutics Hype to Price Pattern
Investor biases related to C4 Therapeutics' public news can be used to forecast risks associated with an investment in CCCC. The trend in average sentiment can be used to explain how an investor holding CCCC can time the market purely based on public headlines and social activities around C4 Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
C4 Therapeutics Implied Volatility | 1.63 |
C4 Therapeutics' implied volatility exposes the market's sentiment of C4 Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if C4 Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that C4 Therapeutics stock will not fluctuate a lot when C4 Therapeutics' options are near their expiration.
The Double Exponential Smoothing forecasted value of C4 Therapeutics on the next trading day is expected to be 2.15 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.89. C4 Therapeutics after-hype prediction price | USD 2.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of C4 Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current CCCC contract
Based on the Rule 16, the options market is currently suggesting that C4 Therapeutics will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-04-17 option contract. With C4 Therapeutics trading at USD 2.15, that is roughly USD 0.00219 . If you think that the market is fully incorporating C4 Therapeutics' daily price movement you should consider acquiring C4 Therapeutics options at the current volatility level of 1.63%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 CCCC Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast C4 Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in C4 Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for C4 Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current C4 Therapeutics' open interest, investors have to compare it to C4 Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of C4 Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in CCCC. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
C4 Therapeutics Additional Predictive Modules
Most predictive techniques to examine CCCC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CCCC using various technical indicators. When you analyze CCCC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
C4 Therapeutics Double Exponential Smoothing Price Forecast For the 25th of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of C4 Therapeutics on the next trading day is expected to be 2.15 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.89.Please note that although there have been many attempts to predict CCCC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that C4 Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
C4 Therapeutics Stock Forecast Pattern
| Backtest C4 Therapeutics | C4 Therapeutics Price Prediction | Buy or Sell Advice |
C4 Therapeutics Forecasted Value
In the context of forecasting C4 Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. C4 Therapeutics' downside and upside margins for the forecasting period are 0.02 and 6.59, respectively. We have considered C4 Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of C4 Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent C4 Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0134 |
| MAD | Mean absolute deviation | 0.0829 |
| MAPE | Mean absolute percentage error | 0.0354 |
| SAE | Sum of the absolute errors | 4.8936 |
Predictive Modules for C4 Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as C4 Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of C4 Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
C4 Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of C4 Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in C4 Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of C4 Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
C4 Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting C4 Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on C4 Therapeutics' historical news coverage. C4 Therapeutics' after-hype downside and upside margins for the prediction period are 0.11 and 6.57, respectively. We have considered C4 Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
C4 Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of C4 Therapeutics is based on 3 months time horizon.
C4 Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as C4 Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading C4 Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with C4 Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 4.44 | 0.02 | 0.00 | 7 Events / Month | 3 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.15 | 2.13 | 0.93 |
|
C4 Therapeutics Hype Timeline
C4 Therapeutics is currently traded for 2.15. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. CCCC is forecasted to decline in value after the next headline, with the price expected to drop to 2.13. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.93%, whereas the daily expected return is currently at -0.25%. The volatility of related hype on C4 Therapeutics is about 27750.0%, with the expected price after the next announcement by competition of 2.15. About 73.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. C4 Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.07. The entity recorded a loss per share of 1.67. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Historical Fundamental Analysis of C4 Therapeutics to cross-verify your projections.C4 Therapeutics Related Hype Analysis
Having access to credible news sources related to C4 Therapeutics' direct competition is more important than ever and may enhance your ability to predict C4 Therapeutics' future price movements. Getting to know how C4 Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how C4 Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OLMA | Olema Pharmaceuticals | 0.04 | 12 per month | 2.91 | 0.14 | 9.82 | (5.86) | 145.73 | |
| VTYX | Ventyx Biosciences | 0.04 | 4 per month | 3.49 | 0.19 | 14.25 | (6.33) | 36.83 | |
| PRTA | Prothena plc | 0.00 | 0 per month | 0.00 | (0.03) | 4.76 | (3.82) | 12.28 | |
| RGNX | Regenxbio | 0.00 | 0 per month | 4.14 | 0.01 | 7.94 | (6.11) | 17.94 | |
| AKBA | Akebia Ther | 0.04 | 8 per month | 0.00 | (0.22) | 5.24 | (6.25) | 32.04 | |
| VSTM | Verastem | 0.00 | 0 per month | 0.00 | (0.08) | 5.37 | (6.80) | 29.76 | |
| GOSS | Gossamer Bio | 0.00 | 0 per month | 4.54 | 0.05 | 7.97 | (6.57) | 27.11 | |
| KALV | Kalvista Pharmaceuticals | 0.00 | 0 per month | 2.97 | 0.14 | 8.43 | (5.03) | 25.15 | |
| ABSI | Absci Corp | 0.04 | 8 per month | 0.00 | (0.11) | 8.58 | (7.91) | 27.80 | |
| CMPX | Compass Therapeutics | 0.00 | 0 per month | 3.04 | 0.15 | 7.61 | (5.34) | 16.14 |
Other Forecasting Options for C4 Therapeutics
For every potential investor in CCCC, whether a beginner or expert, C4 Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CCCC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CCCC. Basic forecasting techniques help filter out the noise by identifying C4 Therapeutics' price trends.C4 Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C4 Therapeutics stock to make a market-neutral strategy. Peer analysis of C4 Therapeutics could also be used in its relative valuation, which is a method of valuing C4 Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
C4 Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how C4 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading C4 Therapeutics shares will generate the highest return on investment. By undertsting and applying C4 Therapeutics stock market strength indicators, traders can identify C4 Therapeutics entry and exit signals to maximize returns.
C4 Therapeutics Risk Indicators
The analysis of C4 Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in C4 Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cccc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.39 | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.66 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for C4 Therapeutics
The number of cover stories for C4 Therapeutics depends on current market conditions and C4 Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that C4 Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about C4 Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
C4 Therapeutics Short Properties
C4 Therapeutics' future price predictability will typically decrease when C4 Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of C4 Therapeutics often depends not only on the future outlook of the potential C4 Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. C4 Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.4 M | |
| Cash And Short Term Investments | 244.9 M |
Check out Historical Fundamental Analysis of C4 Therapeutics to cross-verify your projections. For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of C4 Therapeutics. If investors know CCCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about C4 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.67) | Revenue Per Share | Quarterly Revenue Growth (0.27) | Return On Assets | Return On Equity |
The market value of C4 Therapeutics is measured differently than its book value, which is the value of CCCC that is recorded on the company's balance sheet. Investors also form their own opinion of C4 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is C4 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because C4 Therapeutics' market value can be influenced by many factors that don't directly affect C4 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between C4 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if C4 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, C4 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.